OIS@ASCRS

Diagnostics on the Rise

By Mario Admin | May 26, 2016

Richard Lindstrom, MD, opened up the Diagnostics-Impact on the Premium Channel with an overview of the market including a look at competitors. Video Highlights 00:37…

Read More

CZM Focuses on “A Lot of Little Things” to Move Premium Channel

By Mario Admin | May 25, 2016

Moving cataract surgery outcomes from 80% of patients within 0.5 D of targeted refraction to 95% requires “a lot of little things,” Karlheinz Rein, PhD,…

Read More

Aerie Looks for Rhopressa NDA in Q3

By Mario Admin | May 25, 2016

Aerie Pharmaceuticals has completed all patient visits in two Phase III clinical trials of the Rho kinase inhibitor Rhopressa (netarsudil) 0.02% for treatment of glaucoma…

Read More

Alcon’s Suite Approach to Building the Premium Channel

By Mario Admin | May 25, 2016

As cataract patients’ expectations rise, demanding visual performance on par with refractive surgery, Alcon is striving to meet those high expectations through its Cataract Refractive…

Read More

Physicians Say MIGs Is Transforming Glaucoma Treatment

By Mario Admin | May 25, 2016

Ike K. Ahmed, MD, led a discussion between three notable ophthalmologists treating glaucoma patients with MIGs. The panel followed a presentation by Ahmed and four…

Read More

TearScience Pivots to Focus on Early-Stage OSD

By Mario Admin | May 24, 2016

TearScience, the device company focused on the role of the meibomian glands in dry eye, has pivoted its business model to concentrate more on early-stage…

Read More

TearLab Targets Multiple Biomarkers in Dry Eye

By Mario Admin | May 23, 2016

A physiologically stable ocular surface is a big determinant in cataract and refractive surgery outcomes, so TearLab Corp. is looking to build out its lab-on-a-chip…

Read More

MIGS Market Just Beginning to Hit Its Stride

By Mario Admin | May 23, 2016

Glaucoma is the second leading cause of blindness worldwide, and the number of people with some form of glaucoma is expected to rise to 80…

Read More

Cassini Bets on Total Corneal Analysis to Drive Premium Channel

By Mario Admin | May 23, 2016

The key to growing the toric intraocular lens (IOL) sector for cataract surgery lies in obtaining more accurate measures of total corneal astigmatism, and Cassini…

Read More

IBMD Strives for Femto-like Capsulotomies Without the Cost

By Mario Admin | May 22, 2016

International Biomedical Devices (IBMD) is in preclinical investigation of its ApertureCTC precision capsulotomy device designed to achieve laser-like precision outcomes in cataract surgery, Chief Medical…

Read More

Mynosys Eye Commercial Launch of Zepto

By Mario Admin | May 21, 2016

Zepto represents an “innovative, disposable capsulotomy device,” said president and CEO John Hendrick. It does not disrupt the natural flow of cataract procedures or patient…

Read More

CEO John Hendrick on Zepto’s Fast Development

By Mario Admin | May 21, 2016

Mynosys Cellular Devices is developing Zepto, a disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.